- Home
- MBI vs LXRX Comparison
MBI vs LXRX Comparison
Compare MBI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- LXRX
- Stock Information
- Founded
- MBI 1973
- LXRX 1995
- Country
- MBI United States
- LXRX United States
- Employees
- MBI N/A
- LXRX N/A
- Industry
- MBI Property-Casualty Insurers
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- MBI Finance
- LXRX Health Care
- Exchange
- MBI Nasdaq
- LXRX Nasdaq
- Market Cap
- MBI 377.2M
- LXRX 428.8M
- IPO Year
- MBI 1987
- LXRX 2000
- Fundamental
- Price
- MBI $6.68
- LXRX $1.42
- Analyst Decision
- MBI Buy
- LXRX Buy
- Analyst Count
- MBI 1
- LXRX 5
- Target Price
- MBI $8.00
- LXRX $3.23
- AVG Volume (30 Days)
- MBI 272.0K
- LXRX 2.9M
- Earning Date
- MBI 11-06-2025
- LXRX 11-11-2025
- Dividend Yield
- MBI N/A
- LXRX N/A
- EPS Growth
- MBI N/A
- LXRX N/A
- EPS
- MBI N/A
- LXRX N/A
- Revenue
- MBI $108,000,000.00
- LXRX $58,432,000.00
- Revenue This Year
- MBI N/A
- LXRX $66.55
- Revenue Next Year
- MBI N/A
- LXRX N/A
- P/E Ratio
- MBI N/A
- LXRX N/A
- Revenue Growth
- MBI 285.71
- LXRX 1504.83
- 52 Week Low
- MBI $3.40
- LXRX $0.28
- 52 Week High
- MBI $8.26
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- MBI 37.91
- LXRX 53.45
- Support Level
- MBI $6.65
- LXRX $1.40
- Resistance Level
- MBI $7.07
- LXRX $1.58
- Average True Range (ATR)
- MBI 0.34
- LXRX 0.11
- MACD
- MBI -0.09
- LXRX -0.01
- Stochastic Oscillator
- MBI 29.21
- LXRX 37.45
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and mutual funds. It operates in three segments: the United States Public Finance Insurance, which derives maximum revenue, Corporate, and International & Structured Finance Insurance. U.S. public finance insurance portfolio is managed through the National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.